Anticancer efficacy of Apo2L/TRAIL is retained in the presence of high and biologically active concentrations of osteoprotegerin in vivo.
| Image |  |
|---|---|
| Description | scientific article published on March 2011 |
| Author/s |
author: Andrew Zannettino Vladimir Ponomarev |
| Publication date | March 1, 2011 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |